Strategies for Controlling Afucosylation in Monoclonal Antibodies during Upstream Manufacturing.
Sign Up to like & getrecommendations! Published in 2023 at "Biotechnology journal"
DOI: 10.1002/biot.202200604
Abstract: Core fucosylation is a highly prevalent and significant feature of N-glycosylation in therapeutic monoclonal antibodies produced by mammalian cells where its absence (afucosylation) plays a key role in treatment safety and efficacy. Notably, even slight… read more here.
Keywords: afucosylation; upstream manufacturing; strategies controlling; controlling afucosylation ... See more keywords